{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:49:49Z","timestamp":1792464589288,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000875","name":"Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014912","name":"American Society of Addiction Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA053243"],"award-info":[{"award-number":["R01DA053243"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.amepre.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:08:25Z","timestamp":1721174905000},"page":"878-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pain Management Treatments and Opioid Use Disorder Risk in Medicaid Patients"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9417-7960","authenticated-orcid":false,"given":"Kara E.","family":"Rudolph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3873-9992","authenticated-orcid":false,"given":"Sarah","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-3705","authenticated-orcid":false,"given":"Hillary","family":"Samples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-6918","authenticated-orcid":false,"given":"Rachael K.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2024.07.006_bib0001","unstructured":"Katz J., Sanger-Katz M., Sullivan E. Some key facts about fentanyl. New York Times, https:\/\/www.nytimes.com\/2023\/10\/05\/upshot\/fentanyl-opioids-mexico-explainer.html. Accessed October 25, 2023."},{"key":"10.1016\/j.amepre.2024.07.006_bib0002","unstructured":"National Institute on Drug Abuse. Drug overdose death rates. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates 2023. Accessed October 25, 2023."},{"key":"10.1016\/j.amepre.2024.07.006_bib0003","unstructured":"Centers for Medicare & Medicaid Services. Ongoing emergencies & disasters 2020. https:\/\/www.cms.gov\/About-CMS\/Agency-Information\/Emergency\/EPRO\/Current-Emergencies\/Ongoing-emergencies Accessed October 25, 2023."},{"issue":"5","key":"10.1016\/j.amepre.2024.07.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4514","article-title":"Indication-specific opioid prescribing for US patients with Medicaid or private insurance, 2017","volume":"3","author":"Mikosz","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.amepre.2024.07.006_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/pmt-2018-0070","article-title":"Considerations in addressing the opioid epidemic and chronic pain within the USA","volume":"9","author":"Marshall","year":"2019","journal-title":"Pain Manag"},{"issue":"2","key":"10.1016\/j.amepre.2024.07.006_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.amepre.2024.07.006_bib0007","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/papr.12789","article-title":"Trends of opioid use disorder among hospitalized patients with chronic pain","volume":"19","author":"Orhurhu","year":"2019","journal-title":"Pain Pract"},{"issue":"13","key":"10.1016\/j.amepre.2024.07.006_bib0008","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2024.07.006_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-publhealth-090419-102727","article-title":"A critical review of the social and behavioral contributions to the overdose epidemic","volume":"42","author":"Cerd\u00e1","year":"2021","journal-title":"Annu Rev Public Health"},{"issue":"7","key":"10.1016\/j.amepre.2024.07.006_bib0010","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1017\/S003329172300332X","article-title":"Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid over- dose among Medicaid patients","volume":"54","author":"Hoffman","year":"2024","journal-title":"Psychol Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.07.006_bib0011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/irel.12243","article-title":"Do opioids help injured workers recover and get back to work? The impact of opioid prescriptions on duration of temporary disability","volume":"58","author":"Savych","year":"2019","journal-title":"Ind. Relat."},{"issue":"7","key":"10.1016\/j.amepre.2024.07.006_bib0012","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription","volume":"30","author":"Edlund","year":"2014","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.amepre.2024.07.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2613","article-title":"Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy","volume":"2","author":"Glanz","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amepre.2024.07.006_bib0014","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/MLR.0b013e31824ebd81","article-title":"Doctor and Pharmacy Shop- ping for Controlled Substances","volume":"50","author":"Peirce","year":"2012","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.amepre.2024.07.006_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s11606-019-05545-y","article-title":"Risk of overdose with expo- sure to prescription opioids, benzodiazepines, and non-benzodiazepine sedative-hypnotics in adults: a retrospective cohort study","volume":"35","author":"Cho","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"9","key":"10.1016\/j.amepre.2024.07.006_bib0016","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s11606-018-4532-5","article-title":"Potentially inappropriate opioid prescribing, overdose, and mortality in Massachusetts, 2011\u20132015","volume":"33","author":"Rose","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2024.07.006_bib0017","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/j.pain.0000000000001111","article-title":"Relationship between con- comitant benzodiazepine-opioid use and adverse outcomes among US veterans","volume":"159","author":"Gressler","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.amepre.2024.07.006_bib0018","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addbeh.2018.05.019","article-title":"Disability status and prescription drug misuse among US adults","volume":"85","author":"Ford","year":"2018","journal-title":"Addict Behav"},{"key":"10.1016\/j.amepre.2024.07.006_bib0019","doi-asserted-by":"crossref","first-page":"J760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retro- spective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amepre.2024.07.006_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cpt.1807","article-title":"Risk of opioid overdose associated with concomitant use of opioids and skeletal muscle relaxants: a population-based cohort study","volume":"108","author":"Li","year":"2020","journal-title":"Clin Pharmacol Ther"},{"issue":"13","key":"10.1016\/j.amepre.2024.07.006_bib0021","doi-asserted-by":"crossref","first-page":"e1432","DOI":"10.1212\/WNL.0000000000200904","article-title":"Comparative risk of opioid overdose with concomitant use of prescription opioids and skeletal muscle relaxants","volume":"99","author":"Khan","year":"2022","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.amepre.2024.07.006_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case\u2013 control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"issue":"13","key":"10.1016\/j.amepre.2024.07.006_bib0023","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jama.2022.13659","article-title":"Growing role of gabapentin in opioid-related overdoses highlights misuse po- tential and off-label prescribing practices","volume":"328","author":"Kuehn","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.amepre.2024.07.006_bib0024","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/cpt.3019","article-title":"Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non-Cancer Pain","volume":"114","author":"Corriere","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.amepre.2024.07.006_bib0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40264-017-0595-1","article-title":"All-cause and drug-related medical events associated with overuse of gabapentin and\/or opioid medications: a retrospective cohort analysis of a commercially insured US population","volume":"41","author":"Peckham","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.amepre.2024.07.006_bib0026","article-title":"Adverse outcomes associated with concurrent gabapentin, opioid, and benzodiazepine utilization: A nested case-control study","volume":"13","author":"Olopoenia","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"12","key":"10.1016\/j.amepre.2024.07.006_bib0027","doi-asserted-by":"crossref","first-page":"e2031647","DOI":"10.1001\/jamanetworkopen.2020.31647","article-title":"Association of gabapenti- noids with the risk of opioid-related adverse events in surgical patients in the United States","volume":"3","author":"Bykov","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2024.07.006_bib0028","unstructured":"The Pain Management Best Practices Inter-Agency Task Force. Pain management best practices, inter-agency Task Force Report, Updates, Gaps, Inconsistencies, and Recommendations tech. rep. 2019, https:\/\/www.hhs.gov\/sites\/default\/files\/pain-mgmt-best-practices-draft-final-report-05062019.pdf, Accessed: May 13, 2024."},{"issue":"1","key":"10.1016\/j.amepre.2024.07.006_bib0029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpain.2013.10.002","article-title":"Acceptance and commitment ther- apy for chronic pain: evidence of mediation and clinically significant change following an abbreviated interdisciplinary program of rehabilitation","volume":"15","author":"Vowles","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.amepre.2024.07.006_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.587018","article-title":"Neural mechanisms of acceptance and com- mitment therapy for chronic pain: a network-based fMRI approach","volume":"15","author":"Aytur","year":"2021","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.amepre.2024.07.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2021.110677","article-title":"Mindfulness-oriented recovery enhancement improves negative emotion regulation among opioid-treated chronic pain patients by in- creasing interoceptive awareness","volume":"152","author":"Roberts","year":"2022","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.amepre.2024.07.006_bib0032","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AJP.0000000000000379","article-title":"Mindfulness is associated with increased hedonic capac- ity among chronic pain patients receiving extended opioid pharmacotherapy","volume":"33","author":"Thomas","year":"2017","journal-title":"Clin J Pain"},{"key":"10.1016\/j.amepre.2024.07.006_bib0033","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugalcdep.2018.03.040","article-title":"Dis- positional mindfulness and prescription opioid misuse among chronic pain patients: crav- ing and attention to positive information as mediating mechanisms","volume":"188","author":"Priddy","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.amepre.2024.07.006_bib0034","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s10865-021-00219-9","article-title":"Web-based cognitive behavior therapy for chronic pain patients with aberrant drug-related behavior: How did it work and for whom?","volume":"44","author":"Xie","year":"2021","journal-title":"J Behav Med"},{"key":"10.1016\/j.amepre.2024.07.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108250","article-title":"Episodic future thinking reduces chronic pain sever- ity: A proof of concept study","volume":"215","author":"Craft","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.amepre.2024.07.006_bib0036","series-title":"Causal inference: what if","author":"Hernan","year":"2020"},{"issue":"3","key":"10.1016\/j.amepre.2024.07.006_bib0037","first-page":"19","article-title":"Longitudinal patterns of Medicaid and Medicare coverage among dis- ability cash benefit awardees","volume":"72","author":"Rupp","year":"2012","journal-title":"Soc Secur Bull"},{"issue":"9","key":"10.1016\/j.amepre.2024.07.006_bib0038","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/j.pain.0000000000002920","article-title":"Increasing risk of cannabis use disorder among US veterans with chronic pain: 2005-2019","volume":"164","author":"Mannes","year":"2023","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.amepre.2024.07.006_bib0039","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/pm\/pny247","article-title":"Prevalence of nonopioid and opioid prescriptions among commercially insured patients with chronic pain","volume":"20","author":"Miller","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.amepre.2024.07.006_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid en- rollees","volume":"95","author":"Samples","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"10.1016\/j.amepre.2024.07.006_bib0041","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MLR.0000000000001838","article-title":"Measurement approaches to estimat- ing methadone continuity in opioid use disorder care","volume":"61","author":"Busch","year":"2023","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.amepre.2024.07.006_bib0042","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MLR.0000000000000676","article-title":"An examination of claims-based pre-dictors of overdose from a large Medicaid program","volume":"55","author":"Cochran","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2024.07.006_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108774","article-title":"Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes","volume":"139","author":"Samples","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"542","key":"10.1016\/j.amepre.2024.07.006_bib0044","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/01621459.2021.1955691","article-title":"Nonparametric causal effects based on longitudinal modified treatment policies","volume":"118","author":"D\u00edaz","year":"2023","journal-title":"Journal of the American Statistical Association"},{"issue":"1","key":"10.1016\/j.amepre.2024.07.006_bib0045","doi-asserted-by":"crossref","first-page":"Article 25","DOI":"10.2202\/1544-6115.1309","article-title":"Super Learner","volume":"6","author":"van der Laan","year":"2007","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.amepre.2024.07.006_bib0046","unstructured":"Chen T., He T., Benesty M., et al. xgboost: extreme gradient boosting 2022. R package version 1.6.0.1."},{"key":"10.1016\/j.amepre.2024.07.006_bib0047","first-page":"1","article-title":"Multivariate adaptive regression splines","volume":"19","author":"Friedman","year":"1991","journal-title":"Ann Statist"},{"key":"10.1016\/j.amepre.2024.07.006_bib0048","series-title":"Modern applied statistics with S","author":"Venables","year":"2002"},{"issue":"1","key":"10.1016\/j.amepre.2024.07.006_bib0049","first-page":"1","article-title":"ranger: A fast implementation of random forests for high dimensional data in C++ and R","volume":"77","author":"Wright","year":"2017","journal-title":"J Statis Software"},{"issue":"4","key":"10.1016\/j.amepre.2024.07.006_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09332480.2020.1847958","article-title":"The role of robust statistics in private data analysis","volume":"33","author":"Avella-Medina","year":"2020","journal-title":"Chance"},{"issue":"5","key":"10.1016\/j.amepre.2024.07.006_bib0051","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1097\/PR9.0000000000000827","article-title":"Physical therapy and opioid use for musculoskeletal pain man- agement: competitors or companions?","volume":"5","author":"George","year":"2020","journal-title":"Pain Rep"},{"key":"10.1016\/j.amepre.2024.07.006_bib0052","article-title":"Sensitivity of paid insurance claims data for identifying hospital patients with opioid use disorder","author":"McNeely","year":"2020","journal-title":"Addiction Health Services Research Conference"},{"key":"10.1016\/j.amepre.2024.07.006_bib0053","unstructured":"Medicaid data quality atlas https:\/\/www.medicaid.gov\/dq-atlas\/welcome. Accessed November 10, 2022."}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T11:25:52Z","timestamp":1732188352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0749379724002484"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.07.006","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pain Management Treatments and Opioid Use Disorder Risk in Medicaid Patients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}